SEARCH

SEARCH BY CITATION

References

  • 1
    Stelik J, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: 29th official adult heart transplant report—2012. J Heart Lung Transplant 2012; 31: 10521064.
  • 2
    Schmauss D, Weis M. Cardiac allograft vasculopathy. Circulation 2008; 117: 21312141.
  • 3
    Rahmani M, Cruz RP, Granville DJ, McManus BM. Allograft vasculopathy versus atherosclerosis. Circ Res 2006; 99: 801815.
  • 4
    Caforio AL, Tona F, Fortina AB, et al. Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: Multivariate risk factor analysis and role of immunosuppression. Am J Transplant 2004; 4: 962970.
  • 5
    Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant coronary artery disease detected by coronary angiography: A multiinstitutional study of preoperative donor and recipient risk factors: Cardiac Transplant Research Database. J Heart Lung Transplant 1998; 17: 744753.
  • 6
    van Loosdregt J, van Oosterhout MFM, Bruggink AH, et al. The chemokine and chemokine receptor profile of infiltrating. Cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response. Circulation 2006; 114: 15991607.
  • 7
    Van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1999; 89: 3644.
  • 8
    Hosono M, de Boer OJ, van der Wal AC, et al. Increased expression of T cell activation markers (CD25, CD26, CD40L and CD69) in atherectomy specimens of patients with unstable angina and acute myocardial infarction. Atherosclerosis 2003; 168: 7380.
  • 9
    Kolodgie FD, Gold HK, Virmani R, et al. Intraplaque haemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349: 23162325.
  • 10
    Hellings WE, Peeters W, Moll FL, et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: A prognostic study. Circulation 2010; 121: 19411950.
  • 11
    Takaya N, Yuan C, Chun B, et al. Presence of intraplaque haemorrhage stimulates progression of carotid atherosclerotic plaques: A high resolution magnetic resonance imaging study. Circulation 2005; 111: 27682775.
  • 12
    Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque haemorrhage. Arterioscler Thromb Vasc Biol 2005; 25: 20542061.
  • 13
    Yeagle PL. Cholesterol and the cell membrane. Biochim Biophys Acta 1985; 822: 267287.
  • 14
    Kockx MM, Cromheeke KM, Knaapen MW, et al. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23: 440446.
  • 15
    Li X, van der Meer JJ, van der Loos CM, et al. Microvascular endoglin (CD105) expression correlates with tissue markers for atherosclerotic plaque vulnerability in an ageing population with multivessels coronary artery disease. Histopathology 2012; 61: 8897.
  • 16
    Fleiner M, Kummer M, Mirlacher M, et al. Arterial neovascularization and inflammation in vulnerable patients: Early and late signs of symptomatic atherosclerosis. Circulation 2004; 110: 28432850.
  • 17
    Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death. A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 12621275.
  • 18
    Mehra MR, Crespo-Leiro MG, Dipchand A, et al. International society for heart and lung transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy—2010. J Heart Lung Transplant 2010; 29: 717727.
  • 19
    Stary HC, Chandler CA, Glagov S, et al. A definition of initial, fatty streak and intermediate lesions of atherosclerosis. A report from committee on vascular lesions of the council on atherosclerosis, American Heart Association. Circulation 1994; 89: 24622478.
  • 20
    Stary HC, Chandler CA, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from committee on vascular lesions of the council on atherosclerosis, American Heart Association. Artheriosclerorosis Thromb Vasc Biol 1995; 15: 15121531.
  • 21
    de Boer OJ, van der Loos CM, Teeling P, van der Wal AC, Teunissen MB. Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+ CD25+ T cells in normal skin and inflammatory dermatoses. J Histochem Cytochem 2007; 55: 891898.
  • 22
    Andersson LC, von Willebrand E, Jokinen M, Karhi KK, Gahmberg CG. Glycophorin A as an erythroid marker in normal and malignant hematopoiesis. Haematol Blood Transfus 1981; 26: 338344.
  • 23
    Meijer-Jorna LB, Mekkes JR, van der Wal AC. Platelet involvement in cutaneous leukocytoclasic vasculitis. J Cutan Pathol 2002; 29: 176180.
  • 24
    van der Wal AC, Li X, de Boer OJ. Tissue factor expression in the morphology spectrum of vulnerable atherosclerosic plaques. Semin Thromb Hemost 2006; 32: 4047.
  • 25
    Castellani C, van der Wal AC, De Boer OJ, et al. Virtual histology and the morphologic assessment of cardiac allograft vasculopathy. Am J Transplant 2012; 13: 1109.
  • 26
    Yuan XM, Brunk UT, Olsson AG. Effect of iron and hemoglobin-loaded human monocyte-derived macrophages on oxidation and uptake of LDL. Arterioscler Thromb Vasc Biol 1995; 15: 13451351.
  • 27
    Moguillansky D, Leng X, Carson A, et al. Quantification of plaque neovascularization using contrast ultrasound: A histologic validation. Eur Heart J 2011; 32: 646653.
  • 28
    Dong L, Kerwin WS, Chen H, et al. Carotid artery atherosclerosis: Effect of intensive lipid therapy on the vasa vasorum—Evaluation by using dynamic contrast-enhanced MR imaging. Radiology 2011; 260: 224231.
  • 29
    ten Kate GL, Sijbrands EJ, Valkema R, et al. Molecular imaging of inflammation and intraplaque vasa vasorum: A step forward to identification of vulnerable plaques? J Nucl Cardiol 2010; 17: 897912.
  • 30
    Chen ZY, Yan Lin Y, Yang F, Jiang L, Ge SP. Gene therapy for cardiovascular disease mediated by ultrasound and microbubbles. Cardiovasc Ultrasound 2013; 11: 1114.